CN Patent

CN112203660B — 用于治疗银屑病关节炎的方法

Assigned to Alfasigma SpA · Expires 2024-12-31 · 1y expired

What this patent protects

本发明涉及用于治疗银屑病关节炎的式I的化合物： 或其药学上可接受的盐或其溶剂化物或溶剂化物的盐、包含它们的药物组合物和使用它们的治疗方法，通过施用式I的化合物来进行。

USPTO Abstract

本发明涉及用于治疗银屑病关节炎的式I的化合物： 或其药学上可接受的盐或其溶剂化物或溶剂化物的盐、包含它们的药物组合物和使用它们的治疗方法，通过施用式I的化合物来进行。

Drugs covered by this patent

Patent Metadata

Patent number
CN112203660B
Jurisdiction
CN
Classification
—
Expires
2024-12-31
Drug substance claim
No
Drug product claim
No
Assignee
Alfasigma SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.